Michael J. Kelley

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non–Small Cell Lung Cancer: A Propensity Score–Weighted Analysis

  JCO Oncology Practice · 2026-06-18

• Increasing reach of cancer care: provider perspectives on the value and use of teleoncology

  BMC Health Services Research · 2026-04-11

• Prevalence of Toxic Exposures Among Women Veterans With Breast or Gynecologic Cancers Receiving Veterans Affairs (VA) Care

  Military Medicine · 2025-11-06 · 1 citations

• Characteristics of women Veterans with incident breast and gynecologic cancers in the Veterans Health Administration

  Women s Health · 2025-11-01 · 1 citations

• P2.10.01 Maintenance Pemetrexed/Pembrolizumab vs Maintenance Pembrolizumab Alone in Advanced Non-Squamous Non-Small Cell Lung Cancer

  Journal of Thoracic Oncology · 2025-10-01

• Cancer decentralized clinical trials in the Veterans Health Administration

  JNCI Journal of the National Cancer Institute · 2025-09-23 · 1 citations

• 1666P CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective, non-interventional study of the safety and effectiveness of cemiplimab in immunocompromised/immunosuppressed (IC/IS) patients with advanced cutaneous squamous cell carcinoma (CSCC) at 2 years’ follow-up

  Annals of Oncology · 2025-09-01

• POSTER: CML-841 Treatment Response and Safety of Ponatinib and Asciminib in Patients With Chronic Myeloid Leukemia: A National Veterans Health Administration Analysis

  Clinical Lymphoma Myeloma & Leukemia · 2025-08-28

• CML-841: Treatment Response and Safety of Ponatinib and Asciminib in Patients With Chronic Myeloid Leukemia: A National Veterans Health Administration Analysis

  Clinical Lymphoma Myeloma & Leukemia · 2025-08-28 · 1 citations

• Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patientsPreprint

  medRxiv · 2025-08-15

• Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration

  Cancer · 2025-07-18 · 3 citations

• Using Open-Source Large Language Models to Identify Access to Germline Genetic Testing in Veterans With Breast Cancer From Unstructured Text

  JCO Clinical Cancer Informatics · 2025-07-01 · 1 citations

• <i>SPOP</i> mutations in veterans with metastatic castration-resistant prostate cancer (mCRPC) and the association with race and response to an androgen receptor pathway inhibitor (ARPI).

  Journal of Clinical Oncology · 2025-05-28

• Outcomes of germline expedited point of care (POC) genetic testing through telehealth in the Veterans Health Administration (VA).

  Journal of Clinical Oncology · 2025-05-28

• Enabling national identification of lung cancer screening eligibility with large language models.

  Journal of Clinical Oncology · 2025-05-28

• Real world efficacy and safety of ivosidenib in US veterans with IDH1 mutated cholangiocarcinoma.

  Journal of Clinical Oncology · 2025-05-28 · 2 citations

• CemiplimAb-rwlc survivorship and epidemiology (CASE): Interim results from a prospective study of the safety and effectiveness of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting.

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Multidisciplinary and multi-institutional cancer symptom management strategies in the Veterans Affairs: A mixed methods study.

  Journal of Clinical Oncology · 2025-05-28

• Social vulnerability by neighborhood of association correlates with CAR T referrals.

  Journal of Clinical Oncology · 2025-05-28 · 1 citations

• Somatic Tumor Next-Generation Sequencing in US Veterans With Metastatic Prostate Cancer

  JAMA Network Open · 2025-05-12 · 10 citations